FASEB SRC: The Post-transcriptional Control of Gene Expression Conference: Mechanisms of RNA Decay
FASEB SRC:基因表达转录后控制会议:RNA 衰变机制
基本信息
- 批准号:10467761
- 负责人:
- 金额:$ 0.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-19 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimalsBackBacteriaBiological ProcessBiologyBiomedical ResearchCOVID-19COVID-19 pandemicCessation of lifeClinicalClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCommunicable DiseasesCommunitiesComplexDefectDegradation PathwayDevelopmentEducational workshopEnvironmentEnzymesEukaryotaEvaluationFacultyFloridaFosteringGene ExpressionGene Expression RegulationGenetic DiseasesGenetic TranscriptionGoalsHospitalizationHumanHuman GeneticsJupiterLeadershipLifeLinkMessenger RNAModernizationModificationMolecular BiologyMuscleMutationOrganismPaperParticipantPathway interactionsPatientsPortugalPost-Transcriptional RegulationPostdoctoral FellowProkaryotic CellsProtein BiosynthesisProteinsRNARNA DecayRNA DegradationRNA InterferenceRNA ProcessingRNA VirusesRNA vaccineRegulationResearchResearch PersonnelRespondentSTEM fieldScheduleScientistScourgeSenior ScientistSeriesSiteSpinalSpinal Muscular AtrophyStructureTimeTranscriptional RegulationVirusWomancareercareer developmentclinical applicationcostdisease-causing mutationenzyme pathwayexpectationgraduate studentmRNA Decaymeetingsmenpandemic diseasepathogenic bacteriapathogenic virusplant fungiresponsesenior facultysymposiumtoolvirtual
项目摘要
PROJECT SUMMARY
The understanding that RNA degradation is critical for gene expression traces back to 1959 when Pardee, Jacob
and Monod demonstrated in a historical paper that there had to be an unstable intermediate directing protein
synthesis. More recently, the spectacular use of RNA interference to experimentally degrade specific mRNAs
has expanded the applications of understanding RNA decay mechanisms beyond any expectations. The clinical
applications in the post-transcriptional regulation/RNA field are only starting to be realized with the initial
development of Nusinersen/Spinraza® to successfully treat Spinal Muscular Atrophy and the more recent
description of Milasin® to treat a single patient through a personalized RNA therapy. Of course in late 2019 into
early 2020, RNA burst on to the global stage in a way we could not have predicted with the COVID-19 RNA virus
impacting life as we know it across the globe. Who would or could have guessed that RNA could also represent
a potential path back to a new normal via the rapid development and deployment of the first mRNA vaccines. All
of these examples highlight why The FASEB meeting on ‘Post-transcriptional Regulation of Gene Expression:
Mechanisms of RNA Decay’ is such a timely conference to support at this juncture. This meeting has developed
into a unique conference that brings together the leading experts in RNA decay in humans and other metazoan
animals, plants, fungi, viruses, and bacteria. This meeting is the 12th is a series of FASEB meetings on this topic
where there is a long tradition of sharing key discoveries, building collaborations, and contributing to career
development for junior scientists in the field. This meeting, which, after a two year delay due to the global
pandemic, will be held June 19-23, 2022 in Jupiter, Florida, is being co-organized by three leaders in the RNA
decay field, Dr. Anita H. Corbett from Emory, USA, Dr. Lori Passmore from the MRC in Cambridge UK, and Dr.
Cecilia Arraiano from the ITQB/Universidade NOVA de Lisboa, Portugal. Under this leadership, we propose
three specific aims: 1) Bring together the RNA degradation field and provide a forum for the presentation and
discussion of the latest advances; 2) Provide an inclusive environment for establishing collaborations between
researchers studying RNA degradation with different approaches and in different organisms; and 3) Encourage
productive interactions between a diverse group of both junior scientists and leaders in the RNA degradation
field. In keeping with a meeting goal and a common passion of the organizers, this meeting is organized with a
major commitment to inclusive excellence. Among the 35 invited speakers thus far, there are 18 women (51%)
and 17 men (49%). Each session is chaired by a co-chair team consisting of a senior scientist and a junior
scientist. Among the 18 co-chairs, 11 (61%) are women. We are excited to include five co-chairs who are from
groups traditionally underrepresented in STEM fields (28%). The long-term goal is to continue a successful
meeting series that addresses modern and timely topics in RNA decay and processing while building a diverse
and inclusive community of collaborative scientists and colleagues.
项目摘要
RNA降解对基因表达至关重要的认识可以追溯到1959年,当时Pardee,Jacob
莫诺在一篇历史论文中证明,
合成.最近,RNA干扰在实验上降解特定mRNA的惊人应用
已经超出预期地扩展了理解RNA衰变机制的应用。临床
在转录后调控/RNA领域的应用只是开始实现与最初的
开发Nusinersen/Spinraza®成功治疗脊髓性肌萎缩症,以及最近
本发明涉及Milasin®通过个性化RNA疗法治疗单个患者的描述。当然,在2019年底,
2020年初,RNA以我们无法预测的COVID-19 RNA病毒的方式登上了全球舞台
影响着地球仪上的生命。谁会或可能猜到RNA也可以代表
通过第一批mRNA疫苗的快速开发和部署,这是一条回到新常态的潜在途径。所有
这些例子强调了为什么FASEB会议上的“基因表达的转录后调节:
RNA衰变的机制'是这样一个及时的会议,以支持在这个时刻。这次会议发展了
成为一个独特的会议,汇集了在人类和其他后生动物的RNA衰变的领先专家
动物、植物、真菌、病毒和细菌。本次会议是第12次,是FASEB关于这一主题的一系列会议
在那里,有着分享关键发现、建立合作和为职业生涯做出贡献的悠久传统。
该领域初级科学家的发展。这次会议,其中,经过两年的拖延,由于全球
大流行,将于2022年6月19日至23日在佛罗里达的朱庇特举行,由RNA的三位领导人共同组织
衰变场,安妮塔·H.来自美国埃默里的Corbett博士,来自英国剑桥MRC的洛里帕斯莫尔博士,以及来自英国剑桥大学医学研究中心的Dr.
Cecilia Arraiano来自ITQB/Universidade NOVA de Lisboa,葡萄牙。在这一领导下,我们建议
三个具体目标:1)汇集RNA降解领域,并提供一个论坛的介绍,
讨论最新进展; 2)提供一个包容性的环境,
研究人员用不同的方法和在不同的生物体中研究RNA降解;和3)鼓励
在RNA降解的初级科学家和领导者的不同群体之间的富有成效的互动
领域为了与会议目标和组织者的共同热情保持一致,本次会议以
致力于包容性卓越。迄今为止,在35名受邀发言者中,有18名妇女(51%)
17名男性(49%)。每次会议由一个由一名资深科学家和一名初级科学家组成的联合主席小组主持。
科学家在18名共同主席中,有11名(61%)是妇女。我们很高兴邀请到五位来自
传统上在STEM领域代表性不足的群体(28%)。长期目标是继续成功的
会议系列,解决RNA衰变和加工的现代和及时的主题,同时建立一个多样化的
和包容性的协作科学家和同事的社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANITA H. CORBETT其他文献
ANITA H. CORBETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANITA H. CORBETT', 18)}}的其他基金
A Conserved RNA Binding Protein Required for Control of Key Developmental Pathways
控制关键发育途径所需的保守 RNA 结合蛋白
- 批准号:
10551324 - 财政年份:2022
- 资助金额:
$ 0.65万 - 项目类别:
A Conserved RNA Binding Protein Required for Control of Key Developmental Pathways
控制关键发育途径所需的保守 RNA 结合蛋白
- 批准号:
10391721 - 财政年份:2022
- 资助金额:
$ 0.65万 - 项目类别:
The role of novel oncogenic histone H3 lysine variants in defining a therapeutically actionable epigenetic signature
新型致癌组蛋白 H3 赖氨酸变体在定义治疗上可行的表观遗传特征中的作用
- 批准号:
10436987 - 财政年份:2021
- 资助金额:
$ 0.65万 - 项目类别:
The role of novel oncogenic histone H3 lysine variants in defining a therapeutically actionable epigenetic signature
新型致癌组蛋白 H3 赖氨酸变体在定义治疗上可行的表观遗传特征中的作用
- 批准号:
10290714 - 财政年份:2021
- 资助金额:
$ 0.65万 - 项目类别:
Emory Initiative to Maximize Student Development
埃默里大学最大化学生发展计划
- 批准号:
10417181 - 财政年份:2018
- 资助金额:
$ 0.65万 - 项目类别:
Insight into the RNA processing and decay pathways critical for proper neuronal development and function through focus on mutations that cause Pontocerebellar Hypoplasia
通过关注导致脑桥小脑发育不全的突变,深入了解对神经元正常发育和功能至关重要的 RNA 加工和衰变途径
- 批准号:
10198947 - 财政年份:2018
- 资助金额:
$ 0.65万 - 项目类别:
Insight into the RNA processing and decay pathways critical for proper neuronal development and function through focus on mutations that cause Pontocerebellar Hypoplasia
通过关注导致脑桥小脑发育不全的突变,深入了解对神经元正常发育和功能至关重要的 RNA 加工和衰变途径
- 批准号:
10414387 - 财政年份:2018
- 资助金额:
$ 0.65万 - 项目类别:
Insight Into The RNA Processing And Decay Pathways Critical For Proper Neuronal Development And Function Through Focus On Mutations That Cause Pontocerebellar Hypoplasia
通过关注导致脑桥小脑发育不全的突变,深入了解对神经元正常发育和功能至关重要的 RNA 加工和衰变途径
- 批准号:
10268003 - 财政年份:2018
- 资助金额:
$ 0.65万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 0.65万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 0.65万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 0.65万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 0.65万 - 项目类别:
Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
- 批准号:
23KK0126 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Training Grant